Clinical Trial Update: A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing a Phase 1/2 study of the combination of amivantamab and cetrelimab in participants with metastatic non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Amivantamab (amivantamab)
• Cetrelimab

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING